- Open Access
Correction: The Hippo pathway efector TAZ induces intrahepatic cholangiocarcinoma in mice and is ubiquitously activated in the human disease
Journal of Experimental & Clinical Cancer Research volume 42, Article number: 124 (2023)
Correction: J Exp Clin Cancer Res 41, 92 (2022)
Following publication of the original article , an error was identified in the corresponding author’s affiliation.
The updated affiliation is given below and the changes have been highlighted in bold typeface.
11 National Institute of Gastroenterology, IRCCS- Saverio de Bellis Research Hospital, Castellana Grotte, Italy.
The correction do not affect the overall Conclusion of the article.
Cigliano A, Zhang S, Ribback S, et al. The Hippo pathway effector TAZ induces intrahepatic cholangiocarcinoma in mice and is ubiquitously activated in the human disease. J Exp Clin Cancer Res. 2022;41:192. https://doi.org/10.1186/s13046-022-02394-2.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Cigliano, A., Zhang, S., Ribback, S. et al. Correction: The Hippo pathway efector TAZ induces intrahepatic cholangiocarcinoma in mice and is ubiquitously activated in the human disease. J Exp Clin Cancer Res 42, 124 (2023). https://doi.org/10.1186/s13046-023-02709-x